Home › Funds › Casdin Capital › DNLI
Casdin Capital position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.04M sh
Reported value held$52.60M
Portfolio Weight2.63%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.70M | $85.77M | New |
| Q4 2021 | 1.50M | $66.90M | Reduce |
| Q1 2022 | 1.50M | $48.26M | Hold |
| Q2 2022 | 1.50M | $44.15M | Hold |
| Q3 2022 | 995.00K | $30.54M | Reduce |
| Q4 2022 | 1.30M | $36.15M | Add |
| Q1 2023 | 1.30M | $29.95M | Hold |
| Q2 2023 | 1.30M | $38.36M | Hold |
| Q3 2023 | 1.30M | $26.82M | Hold |
| Q4 2023 | 1.30M | $27.90M | Hold |
| Q1 2024 | 1.30M | $26.68M | Hold |
| Q2 2024 | 1.30M | $30.19M | Hold |
| Q3 2024 | 990.00K | $28.84M | Reduce |
| Q4 2024 | 990.00K | $20.18M | Hold |
| Q1 2025 | 990.00K | $13.46M | Hold |
| Q2 2025 | 890.00K | $12.45M | Reduce |
| Q3 2025 | 890.00K | $12.92M | Hold |
| Q4 2025 | 1.84M | $30.38M | Add |
| Q1 2026 | 1.84M | $35.33M | Hold |
| Q2 2026 | 2.04M | $52.60M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026